Week Ahead in Pulmonology: New Allergy Tx? Spiriva Safety

(MedPage Today) — Is a new ragweed allergy treatment likely to get the FDA green light? Look for that pulmonology information this week, along with more controversy within the link between the tiotropium mist inhaler (Spiriva) and deaths in COPD.

Leave a Reply

Your email address will not be published. Required fields are marked *